Jefferson Park Pediatrics P C
Jefferson Park Pediatrics P C was paid $9.02M by Medicaid between Jan 2018 and Dec 2024, across 87 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 39% of everything it billed.
33Billing provider infoJEFFERSON PARK PEDIATRICS P C
FORT WAYNE, IN 46804
FORT WAYNE, IN 46804
33aNPI1629263181assigned 09/07/2007
33bProvider typeSpecialist
28Total paid$9.02M
24GClaims225,348
24DCodes billed87
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Specialist providers in Indiana
Rank by total paid#3 of 90
Median peer was paid$98K
This provider vs. median92×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 38,430 | $1.36M | |
| 2019 | 39,791 | $1.23M | |
| 2020 | 26,729 | $986K | |
| 2021 | 33,965 | $1.45M | |
| 2022 | 32,273 | $1.44M | |
| 2023 | 30,601 | $1.36M | |
| 2024incomplete | 23,559 | $1.20M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 39% | 62,344 | 50,683 | $3.54M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 10% | 12,010 | 9,856 | $915K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 9.2% | 10,259 | 9,199 | $827K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 7.4% | 8,300 | 7,334 | $668K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 6.9% | 7,658 | 6,908 | $618K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 6.4% | 7,336 | 6,147 | $573K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.9% | 3,459 | 3,005 | $260K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.9% | 11,695 | 4,993 | $173K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.5% | 4,209 | 3,513 | $134K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 1.2% | 4,795 | 3,759 | $108K |
| 41010 | 1.2% | 754 | 685 | $107K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.0% | 6,909 | 5,998 | $94K |
75 more codes
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,871 | $86K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 4,029 | $79K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 6,005 | $71K |
| 17110 | <1% | 923 | $61K | |
| 99460 | <1% | 982 | $57K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,030 | $55K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 1,134 | $49K |
| 80061 | Lipid panel | <1% | 4,754 | $41K |
| 74018 | <1% | 2,184 | $40K | |
| 99383 | <1% | 413 | $36K | |
| 40806 | <1% | 782 | $34K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 432 | $34K |
| 11900 | <1% | 925 | $30K | |
| 17000 | <1% | 636 | $28K | |
| 36416 | <1% | 10,635 | $28K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 535 | $26K |
| 83655 | <1% | 2,420 | $22K | |
| 94010 | <1% | 953 | $22K | |
| 85018 | <1% | 9,631 | $20K | |
| 87807 | <1% | 2,215 | $18K | |
| 99381 | <1% | 208 | $18K | |
| 11901 | <1% | 341 | $16K | |
| 87430 | <1% | 1,345 | $16K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 112 | $14K |
| 69210 | <1% | 669 | $12K | |
| 11301 | <1% | 193 | $11K | |
| 90474 | <1% | 665 | $10K | |
| 81002 | <1% | 3,733 | $9K | |
| 99382 | <1% | 88 | $7K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 1,855 | $7K |
| 11300 | <1% | 143 | $6K | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 663 | $6K |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 1,114 | $5K |
| 99462 | <1% | 173 | $5K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 132 | $4K |
| 54150 | <1% | 33 | $3K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 154 | $2K |
| 99173 | <1% | 2,351 | $2K | |
| 90670 | <1% | 1,843 | $2K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 399 | $2K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,014 | $2K |
| 70360 | <1% | 73 | $1K | |
| 90658 | <1% | 782 | $1K | |
| 99384 | <1% | 12 | $1K | |
| 87420 | <1% | 112 | $1K | |
| 96111 | <1% | 13 | $787.14 | |
| 90698 | <1% | 1,294 | $706.23 | |
| 99000 | <1% | 394 | $693.63 | |
| 90744 | <1% | 1,157 | $320.91 | |
| 70210 | <1% | 14 | $313.14 | |
| 90716 | <1% | 1,353 | $188.94 | |
| 17003 | <1% | 33 | $162.56 | |
| 93000 | <1% | 12 | $145.11 | |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 26 | $83.52 |
| G2010 | Remote evaluation of recorded video and/or images submitted by an established patient (e.g., store and forward), including interpretation with follow-up with the patient within 24 business hours, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment | <1% | 32 | $59.55 |
| 82948 | <1% | 21 | $44.41 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 17 | $29.33 |
| 90707 | <1% | 1,325 | $19.55 | |
| 90677 | <1% | 441 | $2.26 | |
| 90715 | 0% | 747 | $0.00 | |
| 90633 | 0% | 1,480 | $0.00 | |
| 90681 | 0% | 1,025 | $0.00 | |
| 90700 | 0% | 557 | $0.00 | |
| 90734 | 0% | 942 | $0.00 | |
| 90710 | 0% | 12 | $0.00 | |
| 82465 | 0% | 15 | $0.00 | |
| 90648 | 0% | 28 | $0.00 | |
| 90686 | 0% | 263 | $0.00 | |
| 90697 | 0% | 656 | $0.00 | |
| 90657 | 0% | 59 | $0.00 | |
| 90619 | 0% | 457 | $0.00 | |
| 90696 | 0% | 446 | $0.00 | |
| 99174 | 0% | 40 | $0.00 | |
| 90651 | 0% | 29 | $0.00 | |
| 90620 | 0% | 36 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialVEERULA, GIRIDHAR (OWNER)